331 related articles for article (PubMed ID: 25987188)
1. Aurora kinase A in gastrointestinal cancers: time to target.
Katsha A; Belkhiri A; Goff L; El-Rifai W
Mol Cancer; 2015 May; 14():106. PubMed ID: 25987188
[TBL] [Abstract][Full Text] [Related]
2. Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy.
Du R; Huang C; Liu K; Li X; Dong Z
Mol Cancer; 2021 Jan; 20(1):15. PubMed ID: 33451333
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of AURKA Reduces Proliferation and Survival of Gastrointestinal Cancer Cells With Activated KRAS by Preventing Activation of RPS6KB1.
Wang-Bishop L; Chen Z; Gomaa A; Lockhart AC; Salaria S; Wang J; Lewis KB; Ecsedy J; Washington K; Beauchamp RD; El-Rifai W
Gastroenterology; 2019 Feb; 156(3):662-675.e7. PubMed ID: 30342037
[TBL] [Abstract][Full Text] [Related]
4. Aurora kinase targeting in lung cancer reduces KRAS-induced transformation.
Dos Santos EO; Carneiro-Lobo TC; Aoki MN; Levantini E; Bassères DS
Mol Cancer; 2016 Feb; 15():12. PubMed ID: 26842935
[TBL] [Abstract][Full Text] [Related]
5. An update on the pharmacokinetics and pharmacodynamics of alisertib, a selective Aurora kinase A inhibitor.
Durlacher CT; Li ZL; Chen XW; He ZX; Zhou SF
Clin Exp Pharmacol Physiol; 2016 Jun; 43(6):585-601. PubMed ID: 26999067
[TBL] [Abstract][Full Text] [Related]
6. Activation of EIF4E by Aurora Kinase A Depicts a Novel Druggable Axis in Everolimus-Resistant Cancer Cells.
Katsha A; Wang L; Arras J; Omar OM; Ecsedy J; Belkhiri A; El-Rifai W
Clin Cancer Res; 2017 Jul; 23(14):3756-3768. PubMed ID: 28073841
[No Abstract] [Full Text] [Related]
7. Aurora kinase A inhibitors: promising agents in antitumoral therapy.
Malumbres M; Pérez de Castro I
Expert Opin Ther Targets; 2014 Dec; 18(12):1377-93. PubMed ID: 25200357
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for the design of allosteric inhibitors of the Aurora kinase A enzyme in the cancer chemotherapy.
de Souza VB; Kawano DF
Biochim Biophys Acta Gen Subj; 2020 Jan; 1864(1):129448. PubMed ID: 31676293
[TBL] [Abstract][Full Text] [Related]
9. Insights into the non-mitotic functions of Aurora kinase A: more than just cell division.
Bertolin G; Tramier M
Cell Mol Life Sci; 2020 Mar; 77(6):1031-1047. PubMed ID: 31562563
[TBL] [Abstract][Full Text] [Related]
10. Aurora A Kinase Is a Priority Pharmaceutical Target for the Treatment of Cancers.
Damodaran AP; Vaufrey L; Gavard O; Prigent C
Trends Pharmacol Sci; 2017 Aug; 38(8):687-700. PubMed ID: 28601256
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms for nonmitotic activation of Aurora-A at cilia.
Korobeynikov V; Deneka AY; Golemis EA
Biochem Soc Trans; 2017 Feb; 45(1):37-49. PubMed ID: 28202658
[TBL] [Abstract][Full Text] [Related]
12. Aurora kinase A has a significant role as a therapeutic target and clinical biomarker in endometrial cancer.
Umene K; Yanokura M; Banno K; Irie H; Adachi M; Iida M; Nakamura K; Nogami Y; Masuda K; Kobayashi Y; Tominaga E; Aoki D
Int J Oncol; 2015 Apr; 46(4):1498-506. PubMed ID: 25625960
[TBL] [Abstract][Full Text] [Related]
13. Aurora kinases: novel therapy targets in cancers.
Tang A; Gao K; Chu L; Zhang R; Yang J; Zheng J
Oncotarget; 2017 Apr; 8(14):23937-23954. PubMed ID: 28147341
[TBL] [Abstract][Full Text] [Related]
14. Natural anthraquinone compound emodin as a novel inhibitor of aurora A kinase: A pilot study.
Wu FL; Chu PY; Chen GY; Wang K; Hsu WY; Ahmed A; Ma WL; Cheng WC; Wu YC; Yang JC
Chem Biol Drug Des; 2022 Jan; 99(1):126-135. PubMed ID: 34411446
[TBL] [Abstract][Full Text] [Related]
15. p53 deficiency enhances mitotic arrest and slippage induced by pharmacological inhibition of Aurora kinases.
Marxer M; Ma HT; Man WY; Poon RY
Oncogene; 2014 Jul; 33(27):3550-60. PubMed ID: 23955083
[TBL] [Abstract][Full Text] [Related]
16. Issues in interpreting the in vivo activity of Aurora-A.
Shagisultanova E; Dunbrack RL; Golemis EA
Expert Opin Ther Targets; 2015 Feb; 19(2):187-200. PubMed ID: 25384454
[TBL] [Abstract][Full Text] [Related]
17. Dual-Inhibitors of N-Myc and AURKA as Potential Therapy for Neuroendocrine Prostate Cancer.
Ton AT; Singh K; Morin H; Ban F; Leblanc E; Lee J; Lallous N; Cherkasov A
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167327
[TBL] [Abstract][Full Text] [Related]
18. Kinase inhibitor screening reveals aurora-a kinase is a potential therapeutic and prognostic biomarker of gastric cancer.
Mesquita FP; Lucena da Silva E; Souza PFN; Lima LB; Amaral JL; Zuercher W; Albuquerque LM; Rabenhorst SHB; Moreira-Nunes CA; Amaral de Moraes ME; Montenegro RC
J Cell Biochem; 2021 Oct; 122(10):1376-1388. PubMed ID: 34160883
[TBL] [Abstract][Full Text] [Related]
19. Aurora kinase A, a synthetic lethal target for precision cancer medicine.
Mou PK; Yang EJ; Shi C; Ren G; Tao S; Shim JS
Exp Mol Med; 2021 May; 53(5):835-847. PubMed ID: 34050264
[TBL] [Abstract][Full Text] [Related]
20. The Ski Protein is Involved in the Transformation Pathway of Aurora Kinase A.
Rivas S; Armisén R; Rojas DA; Maldonado E; Huerta H; Tapia JC; Espinoza J; Colombo A; Michea L; Hayman MJ; Marcelain K
J Cell Biochem; 2016 Feb; 117(2):334-43. PubMed ID: 26138431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
